Elsevier

The Journal of Hand Surgery

Volume 37, Issue 9, September 2012, Pages 1765-1769
The Journal of Hand Surgery

Scientific article
The Association of Hemoglobin A1c With the Prevalence of Stenosing Flexor Tenosynovitis

https://doi.org/10.1016/j.jhsa.2012.06.007Get rights and content

Purpose

Diabetic patients are susceptible to stenosing flexor tenosynovitis (FTS) and may have a diminished response to treatment. The purpose of this study was to determine whether elevated hemoglobin A1c (HbA1c) levels are associated with the development of FTS.

Methods

A review of our diabetic registry identified a cohort of patients with diabetes mellitus. We stratified this cohort to those with and without a diagnosis of FTS during 2008 based on International Classification of Diseases-9 coding (727.00-727.05J). We reviewed charts to confirm the diagnosis. For patients diagnosed with FTS, we used the HbA1c measurement made closest to the date of diagnosis for analysis. We assessed patients without FTS using an average of HbA1c measurements during the same time period and performed subgroup analysis based on specified HbA1c levels (group A, HbA1c level < 7.0%; group B, HbA1c 7.0% to 7.9%; group C, HbA1c 8.0% to 8.9%; group D, HbA1c ≥ 9.0%). Statistical testing consisted of chi-square analysis, odds ratios, and multivariate regression analysis.

Results

There were 259,927 patients in 2008 identified with diabetes mellitus, 3,952 of whom were diagnosed with FTS. The period prevalence of FTS in this diabetic population was 1.5%. Multivariate regression analysis revealed that HbA1c greater than 7% was an independent risk factor for FTS (odds ratio/confidence interval: group B, 1.31/1.20–1.42; group C, 1.35/1.21–1.51; group D, 1.23/1.10–1.38).

Conclusions

The prevalence of FTS in this diabetic population was considerably lower than expected and may represent a more accurate assessment given the power of this population-based study. In addition, the development of FTS appears to be associated with higher HbA1c levels. Although further study is necessary, this association may be relevant when evaluating and treating diabetic patients with trigger finger.

Type of study/level of evidence

Prognostic III.

Section snippets

Materials and Methods

We obtained institutional review board approval to search the Kaiser Permanente Southern California medical record and diabetic registry databases to identify patients age 18 years and older, with continuous active membership between January 1 and December 31, 2008, who were diagnosed with insulin-dependent or non–insulin-dependent diabetes mellitus before December 31, 2007. Kaiser Permanente Southern California is a not-for-profit community service health care organization providing care to

Results

We identified 259,927 patients with diabetes mellitus who met our inclusion criteria. Flexor tenosynovitis was diagnosed in 3,952 of these patients. From this, we calculated the period prevalence of FTS in the diabetic population to be 15.2/1,000 people (1.5%). Electronic records for the 2008 calendar year were available for 2,129,184 nondiabetic patients greater than 18 years of age. Review of ICD-9 coding identified 15,839 nondiabetic patients diagnosed with FTS. This yields a period

Discussion

Notta,17 a French physician, described stenosing FTS in 1850, and it remains a common tendinopathy of the hand regularly encountered by primary care physicians, general orthopedists, and hand surgeons. The etiology of trigger finger is multifactorial, with localized repetitive friction and systemic disease contributing to its development.1, 18, 19 A considerable body of literature has been published regarding the relationship between FTS and systemic disease, most of which concerns diabetes

References (23)

  • M.J. Saldana

    Trigger digits: diagnosis and treatment

    J Am Acad Orthop Surg

    (2001)
  • Cited by (27)

    • Proportion and distribution of upper extremity musculoskeletal disorders and its association with disability in type 2 diabetes mellitus

      2022, Journal of Hand Therapy
      Citation Excerpt :

      Previous studies have demonstrated decreased hand function in diabetes participants15-17. This can be confirmed by other studies that show a higher prevalence of LJM18-20, Dupuytren's Contracture, FS, and CTS18,21,22 in diabetes participants. The presence of these disorders was found to influence upper extremity pain and disability23.

    • Predictive factors and clinical effects of diabetic hand: A prospective study with 1-year follow-up

      2022, Journal of Plastic, Reconstructive and Aesthetic Surgery
      Citation Excerpt :

      In this context, fibrous hypertrophy or sterile inflammatory changes in the flexor tendon synovium at the A1 pulley can lead to TF, while hypertrophy of the flexor tendon synovium at the wrist can lead to CTS.11 The prevalence of TF in the general population is only 1–2%, although it reaches 5–20% among patients with diabetes.12-14 Previous reports have suggested that age and diabetes duration are related to these changes in hand function,1,15 although the factors predicting the development of diabetic hand (DH) remain unclear.

    • Management of Diabetic Trigger Finger

      2019, Journal of Hand Surgery
      Citation Excerpt :

      Diabetics are more susceptible to developing trigger finger.1 Estimates of the prevalence of trigger finger in the diabetic population range from 5% to 20% compared with 1% to 2% in the general population.2,3 The lifetime incidence of trigger finger in the general population is between 2% and 3%, whereas that in the diabetic population is 10%.4

    • The incidence of trigger digit after carpal tunnel release in diabetic and nondiabetic patients

      2014, Journal of Hand Surgery
      Citation Excerpt :

      For patients with DM, additional information regarding method of disease control (diet-controlled, oral medications, or insulin dependence) and disease severity (HbA1c level) was recorded. In accordance with the method employed by Vance et al,3 diabetic patients were further divided with respect to their HbA1c levels into 4 groups: less than 7.0%, 7.0% to 7.9%, 8.0% to 8.9%, or greater than 9.0%. We recorded HbA1c levels 3 months before and 3 months after CTR.

    View all citing articles on Scopus

    The authors acknowledge Tony S. Yiu and Su-Jau Yang for their contribution to data collection and statistical analysis.

    N.G.H. received support from Kaiser Foundation Healthplans.

    No benefits in any form have been received or will be received related directly or indirectly to the subject of this article.

    View full text